Donanemab-Azbt 350 mg/20 mL Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 350 mg/20 mL
Reference Brands: Kisunla(USA)
Category: Neurology
Donanemab-azbt is a humanized immunoglobulin G1 monoclonal antibody directed against insoluble, N‑truncated pyroglutamate amyloid‑beta found in amyloid plaques in the brains of patients with Alzheimer’s disease. Its mechanism involves binding to these amyloid plaques and facilitating their removal (via microglial-mediated phagocytosis), thereby reducing amyloid burden in the brain. Use of donanemab has been shown to slow cognitive and functional decline in adults with early symptomatic Alzheimer’s disease (mild cognitive impairment or mild dementia) who have confirmed amyloid pathology.
Donanemab-Azbt — third party manufacturing & bulk supply
Donanemab-Azbt 350 mg/20 mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
Indicative minimum order quantity
Donanemab-Azbt is supplied as Injection — an injectable dosage form, so the indicative MOQ is 50,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.
Manufacturers of Donanemab-Azbt listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.
Request a quote for Donanemab-Azbt →Frequently Asked Questions
Donanemab-azbt is an experimental drug under investigation for the treatment of Alzheimer’s disease. It is designed to target and remove amyloid-beta plaques in the brain, which are associated with the progression of Alzheimer’s.
It is made from a humanized monoclonal antibody that specifically binds to modified amyloid-beta proteins in the brain.
There is currently no approved trade name, as the drug is still in clinical trials.
Donanemab is developed by Eli Lilly and Company.
The generic name is donanemab-azbt.
No brand name has been assigned yet.
It is manufactured in specialized biopharmaceutical facilities, primarily in the USA, under controlled conditions for clinical development.
Related Products
Valbenazine
Strength:
40 mg, 60 mg, 80 mg
Form: Capsules
Reference Brands: Ingrezza (USA), Dysval
View Details
Felbamate
Strength:
400 mg, 600 mg, 600mg/5ml
Form: Tablets / Oral suspension
Reference Brands: Felbatol (USA)
View Details
Fenfluramine Hydrochloride
Strength:
2.2 mg/mL, 5 mg/mL
Form: Oral Solution
Reference Brands: Fintepla (USA, EU)
View Details
Quick Response Guaranteed | Verified Suppliers
